Azole derivatives
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- TAISHO PHARMACEUTICAL CO LTD
- Publication Date
- 2016-12-14
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to an azole skeleton compound with antagonistic effect on the V1b receptor of arginine vasopressin (AVP) and a pharmaceutical composition using the compound as an active ingredient, in particular to emotional disorders (including depression), Anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, eating disorder, hypertension, digestive organ disease, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, headache Therapeutic or preventive agents for external trauma, inflammation, immune-related diseases, alopecia and other diseases. Background technique
[0002] Arginine vasopressin (AVP) is a peptide composed of 9 amino acids, which is mainly biosynthesized in the hypothalamus. As a pituitary hormone, it is closely related to the regulation of plasma osmotic pressure, blood pressure and body fluid volume.
[0003] Three subtypes of AVP receptors, V1a,...